Innospera Pharma Inc.
PrivateLast Round
Seed
May 5, 2025
Total Funding Raised
$5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Innospera Pharma Inc. is a biotechnology company that develops small-molecule GPCR modulators for chronic inflammatory, metabolic, and fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innospera Pharma Inc. Comparables
Compare Innospera Pharma Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Liminal BioSciences Inc. | 83% | |
| Galapagos NV | 74% | |
| Structure Therapeutics | 74% | |
Innospera Pharma Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 5, 2025 |
Key People
Founding team and executive leadership
Innospera Pharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Seed |
| Bastien Family Office | Seed |
| Investissement Québec | Seed |
| Anges Quebec | Seed |
| Seido Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 155% MoM.
- Jun 10, 2025
Dr. Glenn Crater appointed as the new Chief Medical Officer.
Innospera Pharma Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Innospera Pharma Inc.'s valuation, stock price, and market status.